Inogen (INGN) EBITDA (2013 - 2026)

Inogen (INGN) has reported EBITDA for 14 consecutive years, with -$5.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBITDA rose 16.85% year-over-year to -$5.1 million in Q2 2026; TTM through Jun 2026 was -$30.9 million, a 6.4% increase from a year earlier, with the FY2025 full-year figure at -$30.2 million, up 28.95% from the prior year.
• EBITDA was -$5.1 million for Q2 2026 at Inogen, up from -$9.3 million in the prior quarter.
• Over five years, EBITDA peaked at -$2.9 million in Q2 2022 and troughed at -$58.5 million in Q4 2022.
• A 5-year average of -$15.7 million and a median of -$9.8 million in 2022 frame the typical range for EBITDA.
• Across the five-year window, EBITDA tumbled 776.5% in 2022 and soared 83.32% in 2024, its largest moves.
• Over 5 years, EBITDA stood at -$58.5 million in 2022, then surged by 50.45% to -$29.0 million in 2023, then soared by 60.71% to -$11.4 million in 2024, then rose by 18.27% to -$9.3 million in 2025, then soared by 45.24% to -$5.1 million in 2026.
• The last three EBITDA figures came in at -$5.1 million (Q2 2026), -$9.3 million (Q1 2026), and -$9.3 million (Q4 2025), per Business Quant data.